| TOPV | Trivalent Oral Polio(myelitis) Vaccine; 경구용 소아마비 혼합백신 |
|---|---|
| WHO ORS | World Health Organization Oral Rehydration Solution osmolality 330; 세계보건기구 경구 수액 용액 |
| AAOM | American Academy of Oral Medicine |
| AAOP | American Academy of Oral Pathology |
| ABOMS | American Board of Oral and Maxillofacial Surgery |
| euglobulin clot lysis time | A measure of the ability of plasminogen activators and plasmin to lyse a clot; normally, clot lysis is determined by the balance of factors which activate fibrinolysis (plasminogen activators and plasmin) and those which inhibit lysis; in certain conditions (e.g., carcinoma or hepatic insufficiency) activating factors predominate and can be measured by noting the time it takes the euglobulin fraction of plasma (excluding inhibitors of fibrinolysis) to clot. (05 Mar 2000) |
|---|---|
| fading time | The time required for a constant stimulus applied to a fixed area of the peripheral visual field to stop. (05 Mar 2000) |
| zero time-binding DNA | DNA that has become the duplex form at the start of a reassociation process. Acronym: DNA (05 Mar 2000) |
| utilization time | The minimum duration of a stimulus of rheobasic strength that is just sufficient to produce excitation. Synonym: temps utile. (05 Mar 2000) |
| forced expiratory time | The time taken to expire a given volume or a given fraction of vital capacity during measurement of forced vital capacity; subscripts specify the exact parameters measured. (05 Mar 2000) |
| left ventricular ejection time | The time measured clinically from onset to incisural notch of the carotid or other pulse; properly the time of ejection of blood from the left ventricle beginning with aortic valve opening and ending with aortic valve closure. (05 Mar 2000) |